FDA approves Roche drugs for rare types of blood, lung cancers – Reuters
ReutersFDA approves Roche drugs for rare types of blood, lung cancersReuters(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer, and to market its drug Alecensa as a first choice of treatment for a subset of ...First Tx for Erdheim-Chester Disease, a Rare Blood CancerMedscapeFDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancerFDA.govFDA Announces First Approval of Targeted Therapy Based on Basket StudyNewswise (press release)GenomeWeb -MedPage Today -Drug Discovery & Development -PharmiWeb.com (press release)all 22 news articles
Original Article: FDA approves Roche drugs for rare types of blood, lung cancers – Reuters
